Items tagged with Treatment
Call to Action to accelerate access to DR-TB drugs: 2016 update (post with simple image)
The update informs about the general progress in the introduction of bedaquiline and delamanid in TB programs worldwide and reports on the requests made in the Call to Action issued in March 2015.
“Towards Ending the Neglect?” DNDi releases update on its paediatric HIV programme (post with simple image)
As the International AIDS Conference kicks off in Durban, the Drugs for Neglected Diseases initiative (DNDi) has released an update on its efforts to develop optimal child-adapted antiretroviral formulations. This document details some recent progress towards its final goal of developing “4-in-1” fixed-dose combinations using the World Health Organization (WHO) recommended treatment regimen for infants and young children. DNDi’s update also discusses some promising developments for treatment for children living with both HIV and tuberculosis (TB).
New clinical practice guidelines: Treatment of drug-susceptible TB (post with simple image)
Jointly developed by the American Thoracic Society, U.S. Centers for Disease Control and Prevention and Infectious Diseases Society of America.
WHO launches Target Regimen Profiles for TB treatment (post with simple image)
The new profiles seek to guide the drug/regimen development process, enabling important drug and regimen features to respond to the needs of end-users, care providers and policymakers.
Kenya becomes first country to introduce new child-friendly TB medicines (post with simple image)
New products expected to improve treatment and child survival from TB; Starting October 1 all children in Kenya initiated on TB treatment will be given the improved formulation.
DR-TB STAT: September 2016 summary and updates (post with simple image)
The DR-TB Scale-Up Treatment Action Team (DR-TB STAT) released its September 2016 update informing about the general progress in the introduction of bedaquiline and delamanid in TB programs worldwide.
Children with TB getting better treatment: rapid roll out of the new child-friendly medicines in 27 countries (post with simple image)
The new child-friendly pediatric TB formulations are being successfully rolled out globally in 27 countries by the Stop TB Partnership’s Global Drug Facility.
Advocates call for the Ministry of Health in Peru to facilitate access to delamanid (post with simple image)
TB advocates encourage the Ministry of Health in Peru to develop country guidance on the use of delamanid for the treatment of drug-resistant TB, a first step to facilitating access.
Breakthrough study demonstrates far shorter, more effective treatment for MDR-TB, with majority cured (post with simple image)
Final results demonstrated nine-month treatment had 82% success rate, compared with previous standard that required more than 20 months of treatment and achieved cure rates below 55%.
Unknown unknowns: poverty and tuberculosis in Romania (post with simple image)
Mircea, a former miner in his fifties, spent the last four years of his life succumbing to Extensively Drug Resistant Tuberculosis (XDR-TB) at the Pines Tuberculosis Sanatorium, which is located high on a mountain. After seven years with this otherwise curable illness, his family wanted little to do with him. He was one of the many patients who doctors in Romania refer to as “social cases” According to Dr. Ionescu at the Pines, patients like Mircea are “repeat clients” with “no chance of escape.” They are people with overlapping social and economic difficulties, such as poverty, homelessness, alcohol use, lack of family support, as well as the social stigma that comes with having TB in Romania.
Page 51 of 53 · Total posts: 0←First 50 51 52 Last→